Weitz and Luxenberg – Jury Awards $9 Billion to Diabetic Put at Cancer Risk by Actos
NEW YORK CITY, N.Y., April 9, 2014 (SEND2PRESS NEWSWIRE) — A Louisiana jury has awarded $9 billion to a New York man who developed bladder cancer after taking Actos, Weitz and Luxenberg announced today. The verdict, issued Monday night, orders Takeda Pharmaceuticals to pay $6 billion in punitive damages, and Eli Lilly to pay $3 billion.